Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.
Cloverleaf Bio develops an RNA therapeutic platform for oncology.
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria.
Tacalyx is a biotech company that develops therapies that target cancer by focusing on tumor-associated carbohydrate antigens.
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.
Wellth motivates medication adherence using Behavioral Economics
EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs.
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Nuevocor operates as a preclinical-stage biotech company.
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions
Glox Therapeutics creates precision antibiotics through the use of engineered protein bacteriocins.
Developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity.
Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.
Asgard Therapeutics is a Biotechnology Company.
Acousia Therapeutics is a privately held biotech company.
Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.
DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
C-mo is the solution providing a complete assessment of cough, adressing key use-cases across the patient management lifecycle.
etherna develops mRNA and lipid nanoparticle solutions.
Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases.
Boehringer Ingelheim Venture Fund has invested in 61 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Boehringer Ingelheim Venture Fund's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Life Science. The firm invests across 21 different industry categories.
Among tracked funding rounds, Nuevocor received $45.0M in a Series B round. Boehringer Ingelheim Venture Fund's total known invested capital is $987.9M.
Boehringer Ingelheim Venture Fund's average investment size is $16.2M across its portfolio of 61 companies.
Recent Boehringer Ingelheim Venture Fund portfolio additions include Rewind Therapeutics, Cloverleaf Bio, smartbax, Tacalyx, Centauri Therapeutics. These companies were founded in 2020 or later.